Electrophoretics International looks to join Alternative Investment Market (AIM)
This article was originally published in Clinica
London-based Electrophoretics International has applied to be admitted to the UK's Alternative Investment Market. The company has a market capitalisation of approximately £80 million ($124 million), following the raising of £4.3 million via two separate placings in August 1994 and September 1995. It has been trading under Rule 4.2 since December 1994.